![conference banner](/images/conference-banner.jpeg)
Abstract
Cancer cells are characterized by a peculiar pH condition, being the extracellular compartment acidic and the intracellular one neutral or basic, i.e. the opposite of what happens in normal cells. The reversal of the pH contributes to cancer cell proliferation and drug resistance. Among the different enzymes regulating pH gradient, proton transporters Na+/H+ exchangers (NHEs) are considered as suitable targets for drugs that ultimately counteract cancer cell survival. This review will describe the properties of NHEs, focusing on the prototype NHE1 and on the effect of its inhibition on cancer cell metabolism.
Keywords: Amiloride, cancer cells, cariporide, NHEs, intracellular pH (pHi), tumor microenvironment, Warburg effect.
Protein & Peptide Letters
Title:Manipulation of Intracellular pH in Cancer Cells by NHE1 Inhibitors
Volume: 23 Issue: 12
Author(s): Francesca Aredia and Anna I. Scovassi
Affiliation:
Keywords: Amiloride, cancer cells, cariporide, NHEs, intracellular pH (pHi), tumor microenvironment, Warburg effect.
Abstract: Cancer cells are characterized by a peculiar pH condition, being the extracellular compartment acidic and the intracellular one neutral or basic, i.e. the opposite of what happens in normal cells. The reversal of the pH contributes to cancer cell proliferation and drug resistance. Among the different enzymes regulating pH gradient, proton transporters Na+/H+ exchangers (NHEs) are considered as suitable targets for drugs that ultimately counteract cancer cell survival. This review will describe the properties of NHEs, focusing on the prototype NHE1 and on the effect of its inhibition on cancer cell metabolism.
Export Options
About this article
Cite this article as:
Aredia Francesca and Scovassi I. Anna, Manipulation of Intracellular pH in Cancer Cells by NHE1 Inhibitors, Protein & Peptide Letters 2016; 23 (12) . https://dx.doi.org/10.2174/0929866523666161013125536
DOI https://dx.doi.org/10.2174/0929866523666161013125536 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A novel NGR-conjugated peptide targets DNA damage responses for radiosensitization
Current Cancer Drug Targets ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Synthesis and Biological Evaluation of 2´-Hydroxy-4´,6´-Diprenyloxychal-Cone Derivatives as Potent CDC25B and PTP1B Inhibitors
Letters in Drug Design & Discovery Nanoparticles: A Neurotoxicological Perspective
CNS & Neurological Disorders - Drug Targets Entropy and Enthalpy in the Activity of Tubulin-Based Antimitotic Agents
Current Chemical Biology Novel Marine-Derived Anti-Cancer Agents
Current Pharmaceutical Design Recent Patents on Imaging Nanoprobes for Brain Tumor Diagnosis and Therapy
Recent Patents on Biotechnology Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience
Current Drug Targets Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck
Recent Patents on Anti-Cancer Drug Discovery Pharmacogenomics of Non-Small Cell Lung Cancer
Current Pharmacogenomics Current Research on Opioid Receptor Function
Current Drug Targets Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells
Current Medicinal Chemistry Adsorptive-Mediated Brain Delivery Systems
Current Pharmaceutical Biotechnology Establishment of Cholinergic Neuron-like Cell Lines with Differential Vulnerability to Nitrosative Stress
Current Neurovascular Research Recent Development in the Fabrication of Collagen Scaffolds for Tissue Engineering Applications: A Review
Current Pharmaceutical Biotechnology Histone Variants and Composition in the Developing Brain: Should MeCP2 Care?
Current Topics in Medicinal Chemistry The Potential of Nanotechnology to Replace Cancer Stem Cells
Current Stem Cell Research & Therapy A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets CD95 Signaling in Cancer Treatment
Current Pharmaceutical Design Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Current Cancer Drug Targets